A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors

Clinical trial NCT02442414 · COMPLETED

Trial details

NCT number: NCT02442414
Sponsor: Sihuan Pharmaceutical Holdings Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2015-04-07
Primary completion: 2019-11-26
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.